Navigation
Trademark Information
Application ID
Status
Date of Application
07 June 2002
Classes
1
Proprietor
Regent Chambers, 7 Th Floor, Jamnalal Bajaj Marg, 208, Nariman Point, Mumbai 400021
Agent
De Penning & De Penning.[15926]
Intellectual Property House 31 South Bank Road Chennai 600028
Type
Device
State
Maharashtra
Country
Filing Mode
Branch Office
IP Office
MUMBAI
Used Since
Valid / Upto
07 June 2032
Description
[Class : 1] Synthetic Resin Adhesive Included In Class 01.
Image (DEVICE)
Uploaded Documents
| 1 | Journal Copy | 11 Nov 2001 |
| 10 | TM-R(RENEWAL OF TRADE MARK) | 07 Jun 2022 |
| 2 | Additional Representation Sheet | 07 Jun 2003 |
| 2 | Other Documents | 07 Jun 2003 |
| 3 | Power of Attorney | 07 Jun 2003 |
| 4 | Examination Report | 07 Jun 2003 |
| 4 | TM-1 | 07 Jun 2003 |
| 5 | Additional Representation Sheet | 07 Jun 2003 |
| 5 | Certificate | 07 Jun 2003 |
| 6 | Note Sheet | 07 Jun 2003 |
| 7 | Certificate | 07 Jun 2003 |
| 7 | Other Documents | 07 Jun 2003 |
| 8 | Examination Report | 07 Jun 2003 |
| 8 | TM-1 | 07 Jun 2003 |
| 9 | TM-12 | 20 Apr 2012 |
Correspondence and Notices
| 1 | O3 NOTICE | 13138618 | 5543930 | 07 Mar 2022 |
| 2 | RENEWAL INTIMATION LETTER | 13633545 | 10 Jun 2022 |
Frequently Asked Questions
When was the trademark applied?
The application for Fevicol sr x-pres (label) was made on 07 June 2002.
Who is the applicant for Fevicol sr x-pres (label)?
The trademark applicant for Fevicol sr x-pres (label) is PIDILITE INDUSTRIES.
In what class is the trademark applied to?
Fevicol sr x-pres (label) is applied in class(es) 1.
What is the status of the trademark application?
Application for Fevicol sr x-pres (label) is on Registered stage.
What is the application ID of the trademark?
Application Id allotted to Fevicol sr x-pres (label) is 1109866.
Who is the trademark agent or attorney?
Trademark agent or attorney for the application is De Penning & De Penning.
What is the type of trademark application?
Fevicol sr x-pres (label) filed with the Intellectual property office as a DEVICE.